Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss
Mohit Sodhi, Ramin Rezaeianzadeh, Abbas Kezouh, et al.
JAMA (2023) Vol. 330, Iss. 18, pp. 1795-1795
Open Access | Times Cited: 208

Showing 26-50 of 208 citing articles:

Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Lixin Guo, Xinhua Xiao
Aging Medicine (2024) Vol. 7, Iss. 1, pp. 5-51
Open Access | Times Cited: 8
Pharmacologic treatments for gastroparesis
Michael Camilleri, Kara Jencks
Pharmacological Reviews (2025) Vol. 77, Iss. 2, pp. 100019-100019
Closed Access | Times Cited: 1
The prevalence and consequences of support for off-label Ozempic prescriptions
Timothy Callaghan, Matthew Motta, Michael Ashley Stein, et al.
Health Economics Policy and Law (2025), pp. 1-14
Open Access | Times Cited: 1
GLP-1 receptor agonists in diabetes and weight loss: the double-edged sword of innovation and risks
Ιoannis Ilias, Lina Zabulienė, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare (2025) Vol. 5
Open Access | Times Cited: 1
Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling
Jingjing Zhang, X. Ye, Xuesong Liu, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 1
Closed Access | Times Cited: 1
A Case of Intussusception With Bowel Obstruction in a Gastric Roux-en-Y Patient Prescribed Semaglutide
S. Pavuluri, Ahmad Toumar, Andrew J. Duffy
Journal of the American College of Emergency Physicians Open (2025) Vol. 6, Iss. 2, pp. 100045-100045
Closed Access | Times Cited: 1
Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
Jamy D. Ard, Donna H. Ryan, Patrick M. O’Neil, et al.
Obesity (2025)
Open Access | Times Cited: 1
Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
Aditi Singh, Sucharita Shadangi, Pulkit Kr. Gupta, et al.
Comprehensive physiology (2025) Vol. 15, Iss. 1
Closed Access | Times Cited: 1
Treatment of obesity in spinal cord injury with tirzepatide: a case report
Michael Juszczak, Kazuko Shem
Spinal Cord Series and Cases (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Oligonucleotide therapies for nonalcoholic steatohepatitis
Sixu Li, Feng Xiong, Songbo Zhang, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102184-102184
Open Access | Times Cited: 7
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations
Marvin G. Chang, Edward A. Bittner
Canadian Journal of Anesthesia/Journal canadien d anesthésie (2024) Vol. 71, Iss. 9, pp. 1302-1315
Closed Access | Times Cited: 7
Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity Management
Kevin Lin, Ateev Mehrotra, Thomas C. Tsai
JAMA Network Open (2024) Vol. 7, Iss. 10, pp. e2441380-e2441380
Open Access | Times Cited: 7
Glucagon-Like Peptide-1 Receptor Agonist Cases Reported to United States Poison Centers, 2017–2022
Christopher E. Gaw, Hannah L. Hays, Cydney A. Kemp, et al.
Journal of Medical Toxicology (2024) Vol. 20, Iss. 2, pp. 193-204
Open Access | Times Cited: 6
Next Generation Weight Loss Drugs for the Prevention of Cancer?
Chantelle Carbonell, Mariet Mathew Stephen, Yibing Ruan, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 6
GLP-1R signaling modulates colonic energy metabolism, goblet cell number and survival in the absence of gut microbiota
Thomas U. Greiner, Ara Koh, Eduard Peris, et al.
Molecular Metabolism (2024) Vol. 83, pp. 101924-101924
Open Access | Times Cited: 6
Access to GLP-1 Weight Loss Drugs in the US, Canada, Switzerland, and Germany
Kerstin Noëlle Vokinger, Emanuel Nussli, Stacie B. Dusetzina
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1002-1002
Closed Access | Times Cited: 6
A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?
Salvatore Docimo, Jay Shah, Gus Warren, et al.
Surgical Endoscopy (2024) Vol. 38, Iss. 11, pp. 6560-6565
Closed Access | Times Cited: 6
Anti-obesity drugs’ side effects: what we know so far
Mariana Lenharo
Nature (2023) Vol. 622, Iss. 7984, pp. 682-682
Closed Access | Times Cited: 14
Enhancing glycaemic control with impetus on weight management: Observing for early worsening of diabetic retinopathy
Sarita Jacob, George Varughese
Eye (2024) Vol. 38, Iss. 10, pp. 1787-1788
Open Access | Times Cited: 5
Challenges of GLP Analog Use for People with Type 1 Diabetes: Issues with Prior Approvals and Tips for Safer Use
Satish K. Garg, Janet K. Snell‐Bergeon, Gurleen Kaur, et al.
Diabetes Technology & Therapeutics (2024) Vol. 26, Iss. 6, pp. 363-366
Closed Access | Times Cited: 5
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review
Janet B. McGill, Irl B. Hirsch, Christopher G. Parkin, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1085-1098
Open Access | Times Cited: 5
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis
Emanuela Talamonti, Jelena Davegardh, Anastasia V. Kalinovich, et al.
Molecular Metabolism (2024) Vol. 85, pp. 101931-101931
Open Access | Times Cited: 5
A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
Lindsay T. Fourman, Josivan Gomes Lima, Vinaya Simha, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 5
A real‐world disproportionality analysis of semaglutide: Post‐marketing pharmacovigilance data
Yikuan Du, Mengting Zhang, Zhenjie Wang, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 10, pp. 1422-1433
Open Access | Times Cited: 5
Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists
Hsuan-Wen Lai, Chun Yin See, Jui‐Yi Chen, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5

Scroll to top